// App-Quantinova.ai

FRI0218 : PREVALENCE, BURDEN OF DISEASE AND HEALTHCARE UTILIZATION AMONG PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) IN JAPAN 2005-2017

Researchers

Presenter

  • K. E. Sada

Principal Investigators

  • Y. Kojo

  • J. Fairburn-Beech

  • K. Sato

  • E. Hayashi

  • S. Akiyama

  • M. Van-Dyke

Medical Centers

  • Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

  • OTS, Tokyo, Japan

  • NCRI, London, United Kingdom

  • GSK R&D, Collegeville, United States of America

Locations

  • Japan

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Eosinophilic granulomatosis with polyangiitis

Biomarkers

  • N/A

Drug/Treatment

  • Prednisone

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved